Cardiol Therapeutics

Recent Finacing

Equity

Recent Raise

$11M

Cardiol Therapeutics is a clinical-stage biotechnology company developing cannabidiol-based therapies for inflammatory heart diseases such as recurrent pericarditis, acute myocarditis, and heart failure.

Ontario, Canada

11-50

Publicly Traded

cardiolrx.com

Highlights

Focus Areas

Biotechnology

Life Science

Nanotechnology

Financials

$99M

Valuation as of 11/13/2025

$11M

Total Raised

1

Funding round

Team

Upgrade to view the team

See the team members at Cardiol Therapeutics.